Press

Contact

For interviews, or anything this page does not carry, write to press@psilocybinlegalization.com. Errors in the record go to a separate desk and are published as dated entries inside the affected record rather than corrected silently; the contact page lists every address and what each one is for.

Fact sheet

Figures as of 19 Aug 2026, the most recent review date in the register. Records are re-reviewed on a tiered cycle, so that is the newest date rather than a date that applies to every entry. Each record carries its own.

Composition. The register holds 100 records: all 50 US states, the District of Columbia, 48 countries and territories, and one federal record that applies across all of them. A layer record sits over its members rather than beside them, so it is excluded from every jurisdiction tally and the United States is never counted twice: 99 of the 100 are peer jurisdictions.

Legal status across the 99 peer jurisdictions. Illegal in 57, decriminalized in 17, mixed in 13, medical use in 8, and legal in 4.

Across the 51 US jurisdictions. Illegal in 37, mixed in 6, decriminalized in 5, legal in 2, and medical use in 1.

Re-review cadence. The ten US jurisdictions where the law is most active are re-verified on a 60 day cycle, every other record on a 180 day cycle, and any record is pulled forward as soon as monitoring picks up movement in it. The ten are named in the methodology. The last reviewed date printed on each record is the authority, not the cycle.

The record in one paragraph

Boilerplate, for use as-is.

The Psilocybin Record is the public record of psilocybin law: source-verified legal status across 99 jurisdictions plus the United States federal layer, an index of 323 registered clinical trials, and a dated changelog of every material change. It is an independent reference published from British Columbia, Canada. It is not legal advice and not medical advice, it makes no claims about the safety or efficacy of any substance, and it does not campaign for or against any change in the law. psilocybinlegalization.com

Name and mark

The name is The Psilocybin Record. The definite article is part of it. Short form: Psilocybin Record. Never initialise it. The mark is the cap glyph, shown here at the two sizes it is drawn for.

The vector is at icon.svg, and raster copies are at 192 pixels and 512 pixels. Take whichever suits the page.

The name and the mark may be reproduced in coverage of this site without asking us first. Two restrictions, and they are the whole of it: do not alter the proportions of the mark or recolor it, and do not use the name or the mark in a way that implies this record endorses a product, a company, or a position on the law.

The social card is og-image.png, 2400 by 1260, regenerated 31 Jul 2026. The set carries no photograph of a person and no product imagery.

Using the data

The facts are free to quote with attribution, and the line below is the one we ask for. Every record page also carries a ready-to-copy citation, which is fuller and satisfies the same request.

Reuse in bulk, redistribution as a feed or a dataset, and reproduction of the compilation inside another product are a separate question, and the license answers it in full. How a record is built, checked, and marked, which is usually the next question, is set out in the methodology.

Embedding the map

The interactive map can sit inside your own article, and it updates itself as the record changes, so a piece filed today does not go stale as the law moves. It is two lines of HTML and needs no permission from us. Build the snippet and choose whether it opens on the world or on a single jurisdiction.

The attribution line comes with the embed and the license covers it, including your right to mark the link rel="nofollow" if your house style requires it. Colours, type and the masthead are not options: the map is the product, and it has to look the same wherever it runs.